Goudsmit Christine, da Veiga Leprevost Felipe, Basrur Venkatesha, Peters Lila, Nesvizhskii Alexey, Walline Heather
Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, MI 48109, USA.
Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA.
Cancers (Basel). 2021 Jul 23;13(15):3714. doi: 10.3390/cancers13153714.
To identify potential extracellular vesicle (EV) biomarkers in head and neck squamous cell carcinoma (HNSCC), we evaluated EV protein cargo and whole cell lysates (WCL) from HPV-positive and -negative HNSCC cell lines, as well as normal oral keratinocytes and HPV16-transformed cells. EVs were isolated from serum-depleted, conditioned cell culture media by polyethylene glycol (PEG) precipitation/ultracentrifugation. EV and WCL preparations were analyzed by LC-MS/MS. Candidate proteins detected at significantly higher levels in EV compared with WCL, or compared with EV from normal oral keratinocytes, were identified and confirmed by Wes Simple Western protein analysis. Our findings suggest that these proteins may be potential HNSCC EV markers as proteins that may be (1) selectively included in EV cargo for export from the cell as a strategy for metastasis, tumor cell survival, or modification of tumor microenvironment, or (2) representative of originating cell composition, which may be developed for diagnostic or prognostic use in clinical liquid biopsy applications. This work demonstrates that our method can be used to reliably detect EV proteins from HNSCC, normal keratinocyte, and transformed cell lines. Furthermore, this work has identified HNSCC EV protein candidates for continued evaluation, specifically tenascin-C, HLA-A, E-cadherin, EGFR, EPHA2, and cytokeratin 19.
为了鉴定头颈部鳞状细胞癌(HNSCC)中潜在的细胞外囊泡(EV)生物标志物,我们评估了来自HPV阳性和阴性HNSCC细胞系、正常口腔角质形成细胞以及HPV16转化细胞的EV蛋白载量和全细胞裂解物(WCL)。通过聚乙二醇(PEG)沉淀/超速离心从血清饥饿的条件性细胞培养基中分离出EV。通过液相色谱-串联质谱(LC-MS/MS)分析EV和WCL制剂。通过Wes Simple Western蛋白分析鉴定并确认了与WCL相比,或与来自正常口腔角质形成细胞的EV相比,在EV中检测到的水平显著更高的候选蛋白。我们的研究结果表明,这些蛋白可能是潜在的HNSCC EV标志物,因为这些蛋白可能(1)被选择性地纳入EV载量中以便从细胞中输出,作为转移、肿瘤细胞存活或肿瘤微环境改变的一种策略,或者(2)代表起源细胞的组成,这可能被开发用于临床液体活检应用中的诊断或预后用途。这项工作表明,我们的方法可用于可靠地检测来自HNSCC、正常角质形成细胞和转化细胞系的EV蛋白。此外,这项工作已经鉴定出了需要持续评估的HNSCC EV蛋白候选物,特别是腱生蛋白-C、HLA-A、E-钙黏蛋白、表皮生长因子受体(EGFR)、EPH受体A2(EPHA2)和细胞角蛋白19。